UCP2 and myocardial infarction: Finally, modeling end-point events using a Cox proportional hazards model adjusted for age, sex, randomized treatment, and BMI, a significant interaction between dysglycemia and UCP2 genotype was observed for combined end-points (p = 0.03), incident myocardial infarction (p = 0.009), and new revascularization procedure (p = 023).